1
|
Eisenberg S, Sehayek E. Remnant particles and their metabolism. BAILLIERE'S CLINICAL ENDOCRINOLOGY AND METABOLISM 1995; 9:739-53. [PMID: 8593123 DOI: 10.1016/s0950-351x(95)80113-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The data described in this chapter demonstrate that the metabolic control of processes responsible for the formation, uptake and clearance of remnant particles is considerably more complex than previously believed. It now appears that several interacting reactions are involved in the process, and evidence is accumulating that defects in any one of these reactions may severely affect the optimal metabolic cascade. Proper exposure of receptor-binding domains in apoE and perhaps apoB-100 molecules is mandatory. Lipoprotein lipase-induced triglyceride hydrolysis is essential and responsible for the formation of remnant particles from secreted triglyceride-rich lipoproteins. The existence of apoE molecules that exhibit normal function is important but perhaps not always essential. Sequestration in the liver through lipoprotein lipase and/or apoE-mediated binding to heparan sulphate ('bridging' effect) appears to play an exceedingly important role during the early phase of the remnant clearance process. The 'bridging' is responsible not only for sequestration in the liver but also for enhanced uptake and lysosomal degradation of the particles. At this stage, association with the remnants of newly secreted, liver-derived apoE molecules may occur and add to the affinity of the particles towards receptors, especially if the new apoE molecules are inserted in a favourable conformational configuration. A role for the hepatic lipase has been suggested but is yet to be proved. Finally, it should be emphasized that remnants are cleared from the plasma predominantly, if not exclusively, following interaction with cellular receptors. Although the LDL receptor avidly internalizes remnant particles and is apparently active in species with a low LDL concentration (e.g. mice and rats), a second specialized and specific receptor or receptors must exist. Whether the LRP is the only remnant receptor or other, as yet unidentified, receptor proteins are also present, remains to be established. Data published in the last few years have begun to elucidate the interactions and consequences of the many reactions and proteins that are involved with the metabolism of remnant lipoproteins. More is to be learned, including the association of remnants in processes that lead to initiation/progression of atherosclerosis.
Collapse
Affiliation(s)
- S Eisenberg
- Institute of Lipid and Atherosclerosis Research, Sheba Medical Center, Tel-Hashomer, Israel
| | | |
Collapse
|
2
|
Smedsrød B, Pertoft H, Gustafson S, Laurent TC. Scavenger functions of the liver endothelial cell. Biochem J 1990; 266:313-27. [PMID: 2156492 PMCID: PMC1131134 DOI: 10.1042/bj2660313] [Citation(s) in RCA: 216] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- B Smedsrød
- Institute of Medical Biology, University of Tromsø, Norway
| | | | | | | |
Collapse
|
3
|
Abstract
Hepatocytes, as the major site of synthesis and terminal catabolism of plasma lipoproteins, exert the major regulatory influence on the concentration of atherogenic lipoproteins in blood plasma and may thereby influence the rate of atherogenesis. The LDL receptor on the microvillous sinusoidal surface of hepatocytes mediates the catabolism of remnants of triglyceride-rich lipoproteins and LDL. Binding of VLDL remnants to the receptor, mediated by apo E, is of very high affinity and presumably multivalent, whereas binding of LDL, mediated by apo B-100, is monovalent and of lower affinity, accounting for the much longer residence time of the latter in the blood. The magnitude of the influx of lipoprotein particles into hepatocytic endosomal compartments dwarfs that of other macromolecules undergoing receptor-mediated endocytosis and terminal catabolism in lysosomes of these cells. The intracellular compartments and processing steps in hepatocytic lipoprotein uptake and degradation are essentially the same as those described for other ligands in the liver and other cells. Receptors with bound lipoproteins migrate into coated pits which become coated vesicles. These vesicles uncoat and fuse to form CURL vesicles and tubules near the cell surface where most receptors are recycled, presumably via receptor-rich appendages that become separated from the vesicles. CURL vesicles become mature MVBs as they migrate to the Golgi/bile canalicular pole of hepatocytes, where they fuse with putative Golgi-derived primary lysosomes and are transformed into heterophagic secondary lysosomes. MVBs also contain a receptor-rich appendage that may recycle some receptors directly to the cell surface or through adjacent Golgi compartments. Dilated ends of trans-Golgi cisternae contain nascent VLDL undergoing packaging for secretion following their synthesis and assembly in the endoplasmic reticulum. Because these "forming secretory vesicles" resemble remnant-filled MVBs, occur in a similar location in the Golgi area of hepatocytes and coisolate in centrifugal fractions of liver homogenates, there has been considerable confusion about the identity of these compartments. With the aid of specific endocytic and exocytic markers, highly purified and morphologically intact endosomal and Golgi compartments can now be obtained from rat liver homogenates. The availability of these and similar fractions of defined purity should facilitate investigation of the hepatocytic processing of endocytosed and secreted macromolecules. Although chylomicron remnants are also taken up by receptor-mediated endocytosis, the nature of the hepatocytic remnant receptor remains elusive.(ABSTRACT TRUNCATED AT 400 WORDS)
Collapse
Affiliation(s)
- R J Havel
- Cardiovascular Research Institute, University of California, San Francisco 94143-0130
| | | |
Collapse
|
4
|
Gustafson S, Vessby B, Ostlund-Lindqvist AM. Apolipoprotein-E-binding proteins of rat liver endothelial cells. BIOCHIMICA ET BIOPHYSICA ACTA 1988; 962:73-80. [PMID: 3416008 DOI: 10.1016/0005-2760(88)90097-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
In an attempt to characterise the apolipoprotein-E-binding proteins of rat liver endothelial cells, we prepared membranes from monolayer cultures of liver endothelial cells as an enriched source of membrane receptors. The membranes could specifically bind iodinated very-low-density lipoproteins (VLDL) and the binding could be inhibited effectively by unlabelled VLDL and high-density lipoproteins, but only moderately by low-density lipoproteins. To identify the binding proteins, we performed immunoprecipitation studies of solubilised iodinated liver endothelial cells and cell membranes, respectively, using purified apolipoprotein E and monospecific polyclonal IgG directed towards this apolipoprotein. The antibodies together with the bound apolipoprotein E and iodinated liver endothelial cell proteins were harvested with staphylococcal protein A-Sepharose. The immunoprecipitates were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis, and after autoradiography of the dried gel, the Mr of the liver endothelial cell proteins bound to apolipoprotein E could be determined. Two protein bands with molecular masses of 55-60 and 110, and a weak band of 170 kDa could be detected from intact cells. These proteins were specifically precipitated only in the presence of divalent cations, and might represent cell-surface receptors for apolipoprotein-E-containing lipoproteins. Additional bands were seen when cell membranes were used, the most prominent ones having molecular masses of 32 and 35 kDa. These proteins could be of intracellular origin, or they may be degradation products of the other apolipoprotein-E-binding proteins.
Collapse
Affiliation(s)
- S Gustafson
- Department of Medical and Physiological Chemistry, Uppsala University, Sweden
| | | | | |
Collapse
|
5
|
Chowdhury A, Chopra DP. Uptake and cellular transport of [11-3H] all-trans-retinoic acid in the liver of vitamin A-deficient hamsters. Tissue Cell 1988; 20:555-65. [PMID: 3238688 DOI: 10.1016/0040-8166(88)90057-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
In this study, we examined, by ultrastructural autoradiography, the uptake and intracellular transport of [3H]all-trans-retinoic acid ([3H]RA) in the livers of vitamin A-deficient hamsters. Four-week-old animals were administered 25 microCi of [3H]RA by gavage, and, at different intervals thereafter, one animal was sacrificed. Their livers were excised and processed for autoradiography. Radioactive grains were observed to pass randomly through the plasma membrane by diffusion. No evidence of retinoid internalization by endocytosis was observed. Between 1 and 30 min after gavage, the radioactivity in parenchymal cells was associated mainly with rough endoplasmic reticulum (RER) and mitochondria. The labeling over nuclei was apparent at 1 min, remained relatively high up to 30 min, and subsequently decreased. At 2 and 5 hr, only a few grains were observed over nuclei, RER and mitochondria. At 24 hr, most of the labeling was associated with endothelial cells and sinusoidal spaces, indicating mobilization of [3H]RA from the liver. The results indicate that [3H]RA is transported through the plasma membrane by transmembrane diffusion without endocytosis and, after entering the cells, the ligand is rapidly translocated into nuclei.
Collapse
Affiliation(s)
- A Chowdhury
- Department of Biochemistry, Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama 35255-5305
| | | |
Collapse
|
6
|
Musliner TA, McVicker KM, Iosefa JF, Krauss RM. Metabolism of human intermediate and very low density lipoprotein subfractions from normal and dysbetalipoproteinemic plasma. In vivo studies in rat. ARTERIOSCLEROSIS (DALLAS, TEX.) 1987; 7:408-20. [PMID: 3606468 DOI: 10.1161/01.atv.7.4.408] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Subfractions of radioiodinated d less than 1.019 g/ml lipoproteins were isolated by nonequilibrium density gradient ultracentrifugation (DGU) from normal and dysbetalipoproteinemic human plasma and were injected into rats. Size and density (d) of lipoprotein products formed over 8 hours were assessed by gradient gel electrophoresis and equilibrium DGU, respectively. Subfractions containing a subspecies of very low density lipoproteins (VLDL) of particle diameter greater than 350 A were cleared rapidly from the plasma and formed only small amounts of low density lipoproteins (LDL). Fractions containing VLDL subspecies of smaller diameter (300 to 350 A) were cleared much more slowly, and formed greater amounts of a discrete LDL product with the characteristics of human LDL-II (peak particle diameter 255 to 265 A, d = 1.030 to 1.040 g/ml). A similar LDL product was formed from subfractions containing intermediate density lipoproteins (IDL). Cholesterol-enriched subspecies within the smaller, denser portion of the IDL spectrum, however, yielded two additional products. One had size and density characteristic of the major human LDL-I subclass reported previously (265 to 275 A, d = 1.025 to 1.030 g/ml), while the other was yet larger (275 to 285 A) and overlapped normal IDL in size and density. In dysbetalipoproteinemic plasma, the metabolic precursors of the largest product were shifted from the IDL to the small VLDL (beta-VLDL) particle distribution. Since beta-VLDL are known to predispose to accelerated atherosclerosis in dysbetalipoproteinemia, it may be that metabolically homologous cholesterol-enriched IDL subspecies in other subjects have similar atherogenic properties.
Collapse
|
7
|
Dashti N, Wolfbauer G. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2. BIOCHIMICA ET BIOPHYSICA ACTA 1986; 875:473-86. [PMID: 3004589 DOI: 10.1016/0005-2760(86)90067-6] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
The regulation of the hepatic catabolism of normal human very-low-density lipoproteins (VLDL) was studied in human-derived hepatoma cell line HepG2. Concentration-dependent binding, uptake and degradation of 125I-labeled VLDL demonstrated that the hepatic removal of these particles proceeds through both the saturable and non-saturable processes. In the presence of excess unlabeled VLDL, the specific binding of 125-labeled VLDL accounted for 72% of the total binding. The preincubation of cells with unlabeled VLDL had little effect on the expression of receptors, but reductive methylation of VLDL particles reduced their binding capacity. Chloroquine and colchicine inhibited the degradation of 125I-labeled VLDL and increased their accumulation in the cell, indicating the involvement of lysosomes and microtubuli in this process. Receptor-mediated degradation was associated with a slight (13%) reduction in de novo sterol synthesis and had no significant effect on the cellular cholesterol esterification. Competition studies demonstrated the ability of unlabeled VLDL, low-density lipoproteins (LDL) and high-density lipoproteins (HDL) to effectively compete with 125I-labeled VLDL for binding to cells. No correlation was observed between the concentrations of apolipoproteins A-I, A-II, C-I, C-II and C-III of unlabeled lipoproteins and their inhibitory effect on 125I-labeled VLDL binding. When unlabeled VLDL, LDL and HDL were added at equal contents of either apolipoprotein B or apolipoprotein E, their inhibitory effect on the binding and uptake of 125I-labeled VLDL only correlated with apolipoprotein E. Under similar conditions, the ability of unlabeled VLDL, LDL and HDL to compete with 125I-labeled LDL for binding was a direct function of only their apolipoprotein B. These results demonstrate that in HepG2 cells, apolipoprotein E is the main recognition signal for receptor-mediated binding and degradation of VLDL particles, while apolipoprotein B functions as the sole recognition signal for the catabolism of LDL. Furthermore, the lack of any substantial regulation of beta-hydroxy-beta-methylglutaryl-CoA reductase and acyl-CoA:cholesterol acyltransferase activities subsequent to VLDL degradation, in contrast to that observed for LDL catabolism, suggests that, in HepG2 cells, the receptor-mediated removal of VLDL proceeds through processes independent of those involved in LDL catabolism.
Collapse
|
8
|
|
9
|
Simionescu N, Simionescu M. Interactions of endogenous lipoproteins with capillary endothelium in spontaneously hyperlipoproteinemic rats. Microvasc Res 1985; 30:314-32. [PMID: 4088094 DOI: 10.1016/0026-2862(85)90063-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
In spontaneously hyperlipoproteinemic old Sprague-Dawley rats, endogenous lipoproteins (LP) in the size range of 15 to 40 nm were directly visualized within the blood vessels due to specimen mordanting with tannic acid. LP morphometric analysis at the level of the endothelium of diaphragm capillaries revealed that particles of the dimensions of low-density lipoproteins, high-density lipoproteins (HDL1), and very low density lipoproteins occur in endothelial structures involved in receptor-mediated endocytosis coated pits-vesicles, endosomes, lysosomes) and transcytosis (plasmalemmal vesicles and transendothelial channels). No such particles could be detected in the intercellular junctions. Intravenously injected cationized ferritin (CF) of pI 8.4 bound uniformly to LP forming an CF-LP complex. Examined at 5, 20, and 60 min after CF administration, the CF-LP complex was found to be taken up by endothelium only by endocytosis (adsorptive via coated pits-vesicles, and fluid phase through a fraction of plasmalemmal vesicles). CF-LP complexes are progressively accumulated within lysosomes. These findings reveal the importance of the net surface charge of macromolecular complexes for their intracellular sorting and fate.
Collapse
|
10
|
Uptake and processing of remnants of chylomicrons and very low density lipoproteins by rat liver. J Lipid Res 1984. [DOI: 10.1016/s0022-2275(20)34458-8] [Citation(s) in RCA: 83] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
11
|
van Berkel TJC, Groot PHE, van Tol A. Interaction of the Reticuloendothelial System with Blood Lipid and Lipoprotein Metabolism. Physiology (Bethesda) 1984. [DOI: 10.1007/978-1-4684-4574-9_13] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
|
12
|
Chajek-Shaul T, Eisenberg S, Oschry Y, Olivecrona T. Metabolic heterogeneity of post-lipolysis rat mesenteric lymph small chylomicrons produced in vitro. J Lipid Res 1983. [DOI: 10.1016/s0022-2275(20)37928-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
13
|
Sewell RB, Mao SJ, Kawamoto T, LaRusso NF. Apolipoproteins of high, low, and very low density lipoproteins in human bile. J Lipid Res 1983. [DOI: 10.1016/s0022-2275(20)37979-7] [Citation(s) in RCA: 56] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
14
|
Stein Y, Kleinman Y, Halperin G, Stein O. Hepatic retention and elimination of cholesteryl linoleyl ether after injection of labeled acetylated LDL or chylomicrons. BIOCHIMICA ET BIOPHYSICA ACTA 1983; 750:300-5. [PMID: 6860683 DOI: 10.1016/0005-2760(83)90032-2] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Rat mesenteric duct chylomicrons labeled with [3H]cholesteryl linoleyl ether and human acetylated low density lipoproteins labeled with [14C]cholesteryl linoleyl ether were injected simultaneously into rats. 3 h after injection 80-90% of the injected radioactivity were recovered in the liver and the ratio of 3H/14C in the liver was the same as in the injected material. The 3H/14C ratio declined gradually over a period of 18 days due to loss of [3H]cholesteryl ether which had been injected with the chylomicrons, and retention of the same compound injected bound to acetylated LDL. The loss from the liver of the chylomicron-bound cholesteryl linoleyl ether was shown to occur through the bile, and its elimination from the body was verified by monitoring fecal excretion. The present results provide evidence that hepatic persistence of a nonhydrolyzable analog of cholesteryl ester is a function of the cell type which has ingested the lipid. Thus, the uptake of labeled chylomicrons by hepatocytes results in a slow but progressive excretion of the nonhydrolyzable lipid through the bile, while the preferential uptake of acetylated LDL by nonparenchymal cells of liver and by the spleen leads to persistence of the lipid in the organ.
Collapse
|
15
|
Eisenberg S. Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system. KLINISCHE WOCHENSCHRIFT 1983; 61:119-32. [PMID: 6843039 DOI: 10.1007/bf01486366] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Data now available suggest that a dynamic equilibrium exists in the plasma lipoproteins. Chylomicrons and very low density lipoproteins (VLDL) are primary secretory products of cells and carry triglycerides through the blood stream. As intravascular triglyceride hydrolysis occurs via the action of lipoprotein lipase (LPL), the further metabolism of nontriglyceride constituents of chylomicrons and VLDL can be followed along two interrelated pathways. Along the core pathway, cholesterol ester increasingly becomes a major core lipid with resultant formation of intermediate density (IDL, or remnant particles) and eventually low density (LDL) lipoprotein. Concomitant with reduction of core volume, redundant surface lipids and proteins move along a surface pathway and either form high density (HDL) lipoprotein precursors, or become associated with existing HDL particles. Cholesterol esters are formed via the action of lecithin: cholesterol acyltransferase (LCAT) in HDL. Therefore, action of LPL and LCAT on triglyceride-rich lipoproteins and their catabolic products is sufficient and necessary for formation, in plasma, of LDL and HDL. Once formed, all plasma lipoproteins are further remodelled by the activity of exchange and transfer reactions. In humans, a major remodelling occurs through exchange of LDL and HDL cholesterol ester by VLDL (and chylomicrons) triglyceride. The reaction is the main source of cholesterol esters in triglyceride-rich lipoproteins and is responsible for the enrichment of LDL and HDL with triglycerides. When followed by triglyceride lipolysis, this cycle results in limitation of size and cholesterol content of both LDL and HDL. The physiology and pathophysiology of the plasma lipid transport system in humans can therefore be fully appreciated only when the interrelations of all these metabolic reactions is taken into account.
Collapse
|
16
|
Oschry Y, Eisenberg S. Rat plasma lipoproteins: re-evaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity. J Lipid Res 1982. [DOI: 10.1016/s0022-2275(20)38046-9] [Citation(s) in RCA: 133] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
17
|
Ittmann MM, Cooper C. Endocytosis of very low density lipoprotein remnants by liver of fasted rats. J Biol Chem 1982. [DOI: 10.1016/s0021-9258(18)33659-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
18
|
Vergani C, Casciarri I, Cargnel A. Lipid disorders in acute viral hepatitis. LA RICERCA IN CLINICA E IN LABORATORIO 1982; 12:107-11. [PMID: 7089420 DOI: 10.1007/bf02909315] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
19
|
Berry EM, Aldini R, Bar-On H, Eisenberg S. Role of the liver in the degradation of very low density lipoproteins: a study of lipolysis by heparin releasable liver lipase and uptake during isolated rat liver perfusion. Eur J Clin Invest 1981; 11:151-9. [PMID: 6791934 DOI: 10.1111/j.1365-2362.1981.tb01834.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
The role of the liver and of a heparin-releasable liver lipase in the metabolism of very low density lipoprotein (VLDL) was investigated in vitro and during recycling rat liver perfusion. Rat plasma VLDL and nascent hepatic VLDL were labelled biosynthetically in their lipid moieties. Incubation in vitro of VLDL with the lipase caused hydrolysis of VLDL-triglycerides (greater than 80%) and VLDL-phosphatidylcholine (greater than 30%). Nascent VLDL was a better substrate for the enzyme. The hydrolytic activities were inhibited by 70--90% when rat plasma (10--30 vol%) was added to the incubation mixture. VLDL-triglycerides and cholesterol esters were taken up by the liver during 180 min recycling perfusion. The rate of disappearance of nascent VLDL was faster than that of plasma VLDL (half-life times of 56.2 +/- 13.9 and 125.0 +/- 24.8 min respectively). Injection of heparin into the perfusion medium caused accelerated uptake of the hydrolysed VLDL-triglyceride by the liver. Addition of plasma (d greater than 1.006 g/ml) to the perfusion at a concentration of 10 vol% delayed the rate of disappearance of VLDL from the perfusate by about 50--75%. These studies have established the capacity of the hepatic lipase to hydrolyse VLDL-lipids and the ability of the liver to degrade nascent and plasma VLDL particles. These two activities, however, are depressed by plasma and therefore previous studies of VLDL metabolism may have to be re-examined when based on incubations or perfusions in the absence of plasma.
Collapse
|
20
|
|
21
|
Chao YS, Jones AL, Hradek GT, Windler EE, Havel RJ. Autoradiographic localization of the sites of uptake, cellular transport, and catabolism of low density lipoproteins in the liver of normal and estrogen-treated rats. Proc Natl Acad Sci U S A 1981; 78:597-601. [PMID: 6941259 PMCID: PMC319101 DOI: 10.1073/pnas.78.1.597] [Citation(s) in RCA: 96] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
The hepatic uptake and catabolism of low density lipoproteins are stimulated severalfold in rats treated with large amounts of 17alpha-ethinylestradiol. To determine the sites within the liver at which these processes occur, (125)I-labeled human low density lipoproteins were injected intravenously into intact control and estradiol-treated rats or added to perfusates of their isolated livers. The livers were fixed by perfusion and processed for light and electron microscopic autoradiography. Distribution of autoradiographic silver grains was estimated qualitatively in light micrographs and quantitatively in electron micrographs. Many more silver grains were seen in livers from estradiol-treated than from control rats, but the processing of labeled low density lipoprotein was indistinguishable. Three minutes after intravenous injection or perfusion of livers, the grains were concentrated over the microvillous surface of parenchymal cells bordering the space of Disse. Many of these grains were within two half-distances from endocytic pits. Only 5-15% of the grains were seen over endothelial and Kupffer cells. Silver grains were also observed over vesicles beneath the plasma membrane whose size and shape suggested that they were derived from fusion of endocytic vesicles. By 15 min, grains were predominantly located in structures like multivesicular bodies in the region of the GERL (Golgi complex-endoplasmic reticulum-lysosomes) near the bile canaliculi. These bodies were packed with small vesicle-like structures and a few larger vesicles, the latter possessing a unit membrane. Between 15 and 30 min, when proteolysis of low density lipoproteins is known to begin, the initially clear matrix of the multivesicular body-like structures became dark and the structures frequently had a dense tail-like appendage. At the same time, silver grains began to appear over secondary lysosomes. These and other results indicate that the hepatic uptake of low density lipoproteins that is stimulated in rats given large amounts of estradiol follows a pathway that closely resembles that of the well-defined "LDL receptor" in cultured cells. In the liver these lipoproteins appear to be transported in endocytic vesicles; the vesicles fuse to form multivesicular body-like structures that acquire lysosomal enzymes and are converted to secondary lysosomes as the lipoproteins are degraded.
Collapse
|
22
|
Jeng Y, Jeng I. A new model for very low density lipoprotein metabolism--nomenclature for very low density lipoprotein derivatives. J Theor Biol 1980; 86:237-45. [PMID: 7442293 DOI: 10.1016/0022-5193(80)90003-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
23
|
Srikantaiah MV, Lew DW, Morin RJ. Inhibition of rat hepatic sterol formation from squalene by plasma lipoproteins. Lipids 1980; 15:555-8. [PMID: 7432102 DOI: 10.1007/bf02534178] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The conversion of 3H-squalene to sterols by rat liver microsomes and cytosol was inhibited by individual rat and human plasma lipoproteins at various concentrations. This inhibition was also observed with added human high density apolipoprotein, but triglycerides, cholesterol, or cholesteryl esters had no inhibitory effects. Lipoproteins and apo high density lipoprotein (HDL) were demonstrated to bind 3H-squalene in vitro. The binding of 3H-squalene by apo HDL could be reversed by increasing concentration of liver cytosol containing sterol carrier protein.
Collapse
|
24
|
van Tol A, van Berkel TJ. Uptake and degradation of rat and human very low density (remnant) apolipoprotein by parenchymal and non-parenchymal rat liver cells. BIOCHIMICA ET BIOPHYSICA ACTA 1980; 619:156-66. [PMID: 7417464 DOI: 10.1016/0005-2760(80)90251-9] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
1. The relative contribution of parenchymal and non-parenchymal cells to the in vivo hepatic uptake of serum apolipoproteins was measured 30 min after intravenous injection of radioiodinated rat very low density lipoprotein (VLDL) remnants, rat and human VLDL, low density lipoprotein (LDL) and high density lipoprotein (HDL). Using rat VLDL, VLDL-remnants, LDL and HDL, respectively, the non-parenchymal cells contain 4.7, 4.9, 6.1 and 5.3 times the amount of trichloroacetic acid-precipitable radioactivity per mg cell protein as compared to parenchymal cells. For human VLDL, LDL and HDL these values are 5.1, 12.0 and 5.9 respectively. 2. The abilities of homogenates of human liver, rat liver parenchymal cells and rat liver non-parenchymal cells to hydrolyze human and rat iodinated VLDL apoprotein were determined by measuring the amount of trichloroacetic acid-soluble (non-iodide) radioactivity liberated upon incubation at the optimal pH of 4.2. Non-parenchymal cells possess a 8--21-fold higher maximal capacity to degrade VLDL apoprotein per mg of cell protein than parenchymal cells. This factor is 5--6 for VLDL-remnant apoprotein degradation measured at low (suboptimal) apolipoprotein concentrations. 3. It is concluded that, in addition to parenchymal cells, the non-parenchymal cells play an important role in the hepatic uptake and possibly degradation of VLDL-(remnant) apoprotein.
Collapse
|
25
|
Windler E, Chao Y, Havel R. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J Biol Chem 1980. [DOI: 10.1016/s0021-9258(19)70811-4] [Citation(s) in RCA: 207] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
26
|
|
27
|
Eisenberg S. Plasma lipoprotein conversions: the origins of low-density and high-density lipoproteins. Ann N Y Acad Sci 1980; 348:30-47. [PMID: 6994564 DOI: 10.1111/j.1749-6632.1980.tb21289.x] [Citation(s) in RCA: 82] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
28
|
Hashimoto S, Dayton S. Stimulation of cholesterol esterification in hepatic microsomes by lipoproteins from normal and hypercholesterolemic rabbit serum. BIOCHIMICA ET BIOPHYSICA ACTA 1979; 573:354-60. [PMID: 444555 DOI: 10.1016/0005-2760(79)90068-7] [Citation(s) in RCA: 31] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Incubation of plasma lipoproteins with rabbit hepatic microsomes enriched the microsomes with free cholesterol and stimulated cholesterol esterification. The rate of cholesterol esterification correlated well (r = 0.96) with the concentration of microsomal free cholesterol. Lipoproteins from normal and hypercholesterolemic serum varied in their propensity to stimulate cholesterol esterification. Among the normal lipoproteins, low density lipoproteins was more stimulatory than either high density lipoproteins or intermediate density lipoproteins. However, the intermediate density lipoproteins fraction from hypercholesterolemic serum was consistently more stimulatory than any of the normal lipoproteins. The augmentation of cholesterol content, when microsomes were exposed to mixed hyperlipidemic lipoproteins, was proportionately much greater than augementation of phospholipid or protein concentration.
Collapse
|
29
|
Florén CH, Nilsson A. Uptake and degradation of iodine-labelled chylomicron remnant particles by monolayers of rat hepatocytes. Biochem J 1978; 174:827-38. [PMID: 728089 PMCID: PMC1185988 DOI: 10.1042/bj1740827] [Citation(s) in RCA: 37] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
1. Rat chylomicrons were labelled with 125I with 69--72% of the iodine in the protein moiety. Less than 1 nmol of iodine was incorporated per nmol of protein. Of the peptide radioactivity 44--56% was in apolipoprotein A-1, 30--40% in the C peptides and 11--15% in apolipoprotine B. The arginine-rich peptide, which accounted for about 14% of the chylomicron protein mass as determined by scanning of sodium dodecyl sulphate-polyacrylamide gels, contained very little radioactivity. 2. Chylomicron remnants generated with postheparin plasma from iodine-labelled chylomicrons showed a relative increase in the percentage of the arginine-rich peptide (76--90% of the apolipoprotein mass according to gel scanning). The major portion of the peptide iodine label was present in apolipoprotein A-1 (43--57%), B (22--32%) and C peptides (17--35%). 3. When iodine-labelled chylomicron remnants were added to rat hepatocytes in primary culture, labelled peptides were taken up and degraded by the hepatocytes by a saturable process. The Vmax. for the uptake was calculated to the 300ng of protein/h per mg of cell protein and the apparent Km as 7.7 microgram of protein/mg of cell protein. A larger proportion of the 125I-labelled lipids of the remnants (mainly polar lipids) was taken up. This suggest that these may also enter the cells by a mechanism that does not involve particulate uptake, such as phospholipid exchange. 4. The degradation of labelled peptides was inhibited by colchicine, concanavalin A, chloroquine and NH4Cl, which also inhibit degradation of the cholesteryl ester portion. All these drugs exerted their inhibition mainly after the uptake of labelled peptide. No degradation occurred at 4 degrees C, and also the uptake was markedly decreased. 5. The uptake of labelled chylomicron remnant peptide was 77 times as effective as that of labelled sucrose, which is likely to be taken up randomly by pinocytosis.
Collapse
|
30
|
|
31
|
Lipkin EW, Cooper C, Shipley RA. The contribution of serum triacylglycerol to hepatic triacylglycerol turnover in the starved rat. Biochem J 1978; 172:205-18. [PMID: 666739 PMCID: PMC1185685 DOI: 10.1042/bj1720205] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
The present study was undertaken to evaluate quantitatively the turnover of serum triacylglycerol (triglyceride) in the starved rat and to determine whether serum triacylglycerol recycled to liver contributes a significant fraction of the total hepatic triacylglycerol turnover. Serum was labelled in vitro with [3H]trioleoylglycerol (glycerol [3H]trioleate) to provide uniform labelling of all lipoprotein species. By using the curves describing disappearance of isotope from serum and its appearance in liver, rate constants for movement of triacylglycerol out of serum (0.29 min-1) and the uptake of serum triacylglycerol by liver (0.22 min-1) were calculated. The total rate of movement (flux) of triacylglycerol in these processes, the product of rate constant and serum pool size, was calculated to be 0.39 and 0.29 mg/min per 100 g body wt. respectively. A model is postulated for whole-body triacylglycerol metabolism consistent with the present data as well as most observations in the literature. From the model it can be predicted that: (1) the entire turnover of liver triacylglycerol in the starved rat can be accounted for on the basis of contributions from serum non-esterified fatty acid and serum triacylglycerol; (2) the entire turnover of the serum triacylglycerol pool can be accounted for quantitatively on the basis of contributions from intestine and liver; (3) the release rate for triacylglycerol from liver should be 0.34 to 0.35 mg/min per 100 g body wt.; (4) triacylglycerol synthesized by liver from non-esterified fatty acid of serum and by intestine can account quantitatively for the irreversible disposal rate of triacylglycerol from serum.
Collapse
|
32
|
Florén CH, Nordgren H, Nilsson A. Effects of chloroquine and colchicine on the degradation of chyle cholesteryl ester and phospholipids in vivo. EUROPEAN JOURNAL OF BIOCHEMISTRY 1977; 80:331-40. [PMID: 923583 DOI: 10.1111/j.1432-1033.1977.tb11887.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
33
|
Chajek T, Friedman G, Stein O, Stein Y. Effect of colchicine, cycloheximide and chloroquine on the hepatic triacylglycerol hydrolase in the intact rat and perfused liver. BIOCHIMICA ET BIOPHYSICA ACTA 1977; 488:270-9. [PMID: 889866 DOI: 10.1016/0005-2760(77)90184-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
34
|
Drevon CA, Berg T, Norum KR. Uptake and degradation of cholesterol ester-labelled rat plasma lipoproteins in purified rat hepatocytes and nonparenchymal liver cells. BIOCHIMICA ET BIOPHYSICA ACTA 1977; 487:122-36. [PMID: 192303 DOI: 10.1016/0005-2760(77)90049-2] [Citation(s) in RCA: 70] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
1. A new method for isolation and purification of rat liver hepatocytes and nonparenchymal cells by differential centrifugation is described. 2. Cholesterol ester-labelled lipoproteins (prepared by the action of lecithin: cholesterol acyltransferase) intravenously injected were taken up by hepatocytes and nonparenchymal cells. 3. Hepatocytes and nonparenchymal cells in suspension were able to take up and hydrolyse the cholesterol ester portion of lipoproteins. 4. Uptake of cholesterol ester labelled whole rat plasma and high density lipoproteins (HDL) increased with increasing concentrations until a distinct saturation level was reached in hepatocytes. In nonparenchymal cells there was no saturation of lipoprotein uptake. 5. Concanavalin A inhibited cholesterol ester-labelled lipoprotein uptake in hepatocytes, indicating that the uptake at least partially depends on carbohydrate sites on the cell surface. The uptake in nonparenchymal cells was unaffected of concanavalin A. 6. The specific activity of the acid cholesterol ester hydrolase was the same in homogenates from hepatocytes and nonparenchymal cells while acyl-CoA: cholesterol acyltransferase was found almost exclusively in hepatocytes.
Collapse
|
35
|
Stein Y, Ebin V, Bar-On H, Stein O. Chloroquine-induced interference with degradation of serum lipoproteins in rat liver, studied in vivo and in vitro. BIOCHIMICA ET BIOPHYSICA ACTA 1977; 486:286-97. [PMID: 189819 DOI: 10.1016/0005-2760(77)90024-8] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The effect of chloroquine, an inhibitor of certain lysosomal enzymes including cathepsin B (EC 3.4.22.1), on the degradation of serum lipoproteins in rat liver was studied in vivo and in liver homogenates. Chloroquine had no effect on the clearance from the circulation of 125I-labeled rat or human very low density lipoproteins or human low density lipoproteins. Pretreatment with chloroquine for 3 h, resulted in a 2-2.5 fold increase in 125i-labeled very low density lipoprotein recovered in the liver 45 min after injection of the homologous and heterologous lipoproteins. This effect was evident on both the 125I-labeled protein and 125I-labeled lipid moiety. 30 min after the injection of [3H]-cholesterol linoleate-labeled very low density lipoproteins, 70% of the injected label was recovered in the liver, both in control and chloroquine-treated rats. Since the perl and 20% in the experimental group, it was concluded that chloroquine interferes with the hydrolysis of [3H]cholesterol linoleate. Following injection of 125I-labeled human low density lipoproteins only 4% of the injected lipoprotein was recovered in the liver of control rats and not more than 10% after chloroquine treatment, when about 50% had been cleared from the circulation. Hence, while very low density lipoprotein protein and cholesterol ester are catabolized in the liver, the catabolism of low density lipoproteins occurs mainly in extra-hepatic tissues. Using post-nuclear liver suprnatant, optimal degradation of various serum lipoproteins was found at pH 4.4, and chloroquine inhibited their degradation. Degradation of very low density and low density lipoproteins was completely inhibited at 0.05 M chloroquine, while less pronounced inhibition was seen with high density lipoproteins, apolipoproteins and apolipoprotein AI. These results indicate that liver acid hydrolases in vivo participate in the degradation of serum lipoproteins. Cathepsin B is apparently responsible for the degradation of aplipoprotein B, while other cathepsins might also be active in the degradation of this and the other apolipoproteins.
Collapse
|
36
|
Florén CH, Nilsson A. Degradation of chylomicron remnant cholesteryl ester by rat hepatocyte monolayers. Inhibition by chloroquine and colchicine. Biochem Biophys Res Commun 1977; 74:520-8. [PMID: 836305 DOI: 10.1016/0006-291x(77)90335-7] [Citation(s) in RCA: 27] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
37
|
Havel RJ. The origin and fate of chylomicrons and VLDL. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1977; 82:406-12. [PMID: 200100 DOI: 10.1007/978-1-4613-4220-5_97] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
38
|
Stein Y, Stein O. The origin and fate of LDL. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1977; 82:413-20. [PMID: 200101 DOI: 10.1007/978-1-4613-4220-5_98] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
39
|
Nakai T, Otto PS, Whayne TF. Proteolysis of canine apolipoprotein by acid proteases in canine liver lysosomes. BIOCHIMICA ET BIOPHYSICA ACTA 1976; 422:380-9. [PMID: 174745 DOI: 10.1016/0005-2744(76)90149-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Canine liver lysosomes were purified by sucrose discontinuous density gradient centrifugation and then ruptured by sonication to obtain the soluble fraction. This soluble lysosomal fraction, which contained a 25-fold increase in acid phosphatase activity per mg of total protein when compared with the original homogenate, was incubated with a subfraction (1.110 less than d less than 1.210 g/cm3, HDL3) of canine high density lipoproteins (HDL) at pH 3.8. HDL3 proteolysis by lysosomal proteases, measured as the release of peptides and amino acids by the ninhydrin reaction, followed hyperbolic curves with straight lines (r = 0.99) obtained on Lineweaver-Burk plots. Km calculated from the Lineweaver-Burk plot was 635 mug of HDL3 protein per 0.5 ml of incubation mixture. Optimum HDL3 proteolysis was observed from pH 3.8 to 4.5. Incubation with the other subcellular organelle fractions did not result in HDL3 proteolysis. To evaluate the effects of enzyme inhibitors, iodoacetate, p-chloromercuribenzoate (both specific for the endopeptidase, cathepsin B (EC 3.4.22.1)) and pepstatin (specific for the endopeptidase, cathepsin D (EC 3.4.23.5) were tested. Iodoacetate and p-chloromercuribenzoate inhibited HDL3 proteolysis 100% and bovine serum albumin proteolysis 65%. Pepstatin inhibited HDL3 proteolysis 45% and bovine serum albumin proteolysis 70%. The in vitro data presented support the hypothesis that hepatic lysosomes play an important role in HDL3 catabolism in the dog. Furthermore, results obtained from enzyme inhibition studies suggest that a specific lysosomal endopeptidase, cathepsin B, may play the key role in HDL3 proteolysis.
Collapse
|
40
|
Goodman ZD, Lequire VS. Transfer of esterified cholesterol from serum lipoproteins to the liver. BIOCHIMICA ET BIOPHYSICA ACTA 1975; 398:325-36. [PMID: 1182142 DOI: 10.1016/0005-2760(75)90148-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The fate of cholesteryl esters of the serum lipoproteins was studied in intact rats and in isolated perfused rat livers. The lipoproteins of fasting rat serum were labeled in vitro with [3H]cholesteryl oleate. Following intravenous injection, it was found that the majority of the radioactive ester was rapidly taken up by the liver where hydrolysis of the ester bond occurred. At 5 min, 58% of the injected material was recovered in the liver, 85% of which was still in the ester form, while at 30 min only 22% of the liver radioactivity was in cholesteryl esters. There was very little difference in the rate at which radioactivity was taken up from the different lipoprotein classes. Similar phenomena were observed in the perfused liver, but it was found that although the radioactive esters were being taken up, there was no change in the concentrations of free or esterified cholesterol in the perfusing medium, indicating that the lipoprotein cholesteryl ester was gaining access to the liver through an exchange of molecules. After uptake, cell fractionation experiments showed that the plasma membranes had the greatest relative amounts of radioactivity, suggesting that this is the site of exchange. Small amounts of radioactivity were recovered in the bile, demonstrating that serum lipoproteins can serve as precursors of at least some of the bile steroids.
Collapse
|
41
|
Portman OW, Illingworth DR, Alexander M. The effects of hyperlipidemia on lipoprotein metabolism in squirrel monkeys and rabbits. BIOCHIMICA ET BIOPHYSICA ACTA 1975; 398:55-71. [PMID: 167856 DOI: 10.1016/0005-2760(75)90169-1] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
We studied the metabolism of different classes of lipoprotein in squirrel monkeys and rabbits. Lipoproteins were labeled in vivo in donor animals with (3H)leucine and (3H)cholesterol. The rate of disappearance from plasma of recipient squirrel monkeys of the protein moiety of the very low density lipoproteins was rapid, that of high density lipoproteins slow, and the rate for low density lipoproteins was intermediate. The fractional turnover of the apoprotein of low density lipoproteins was slightly reduced in hyperlipidemic monkeys, but the absolute rates of synthesis and catabolism were increased. Hyperdipidemia in rabbits resulted in a dramatic reduction in the fractional catabolic rate of low density lipoprotein apoprotein. Hyperlipidemia in the donors of biosynthetic low density lipoproteins also influenced the rates of catabolism in rabbits. We showed the cycloheximide that although there was recycling of (3H)leucine into other proteins, the reutilization of leucine from low density lipoproteins for nascent low density lipoproteins was not significant. In most tissues the ratio of cholesterol:protein radioactivity was much greater than that for plasma 24 h after administration of labeled low density lipoproteins, but the ratios for aortic intima plus inner media and for plasma low density lipoproteins were similar. The presence of atherosclerosis resulted in a large increase in the apparent uptake of low density lipoproteins by the aortas of rabbits and monkeys.
Collapse
|
42
|
Noel SP, Dolphin PJ, Rubinstein D. An in vitro model for the catabolism of rat chylomicrons. Biochem Biophys Res Commun 1975; 63:764-72. [PMID: 1131262 DOI: 10.1016/s0006-291x(75)80449-9] [Citation(s) in RCA: 58] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
43
|
Eisenberg S, Rachmilewitz D, Levy RI, Bilheimer DW, Lindgren FT. Pathways of lipoprotein metabolism: integration of structure, function and metabolism. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1975; 63:61-76. [PMID: 173155 DOI: 10.1007/978-1-4684-3258-9_4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
44
|
Lipoprotein Metabolism1 1In preparation of this study, Dr. Eisenberg was supported in part through the Special Foreign Currency Program of the National Library of Medicine, National Institutes of Health, Public Health Service, U. S. Department of Health, Education, and Welfare, Bethesda, Maryland, under an agreement with the Israel Journal of Medical Sciences, Jerusalem, Israel. ADVANCES IN LIPID RESEARCH 1975. [DOI: 10.1016/b978-0-12-024913-8.50008-4] [Citation(s) in RCA: 235] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|